Skip to main content
search
Main navigation
Home
About
About ACSH
Financials
Our Team
Donate
Publications
Media/Contact
Subscribe
Write For Us
risk vs. benefit
email
facebook
twitter
linkedin
pocket
reddit
print
4 Prescription Drugs People Love
In 2019, I wrote an article called "4 Prescription Drugs People Hate." It was rather popular.
Read more
Non-Opioid Drugs That Can Be Dangerous and Habituating. Should We Ban Them?
Just about any drug can be made to look bad, especially when its risks are considered in the absence of its benefits.
Read more
Subscribe to risk vs. benefit
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
From a Drop of Blood to a Genome: The Future of Newborn Screening
How the Zantac Litigation Went Sour
The Anniversary of FDA's Landmark Approval of Genetically Engineered Human Insulin: A Cautionary Tale
NSAIDs: Pick Your Poison
Vani Hari, Eva Mendes, and the Erosion of Expertise
ACSH Podcasts
Podcast: Should Scientists Deliberately Give People COVID?
Podcast: FDA Finally Listening to Reason on Opioids?
Podcast: Is Science Too Political? If So, What Do We Do About It?
Podcast: The Profit Motive Behind 'Make America Healthy Again'
Podcast: Gender-Affirming Care for Kids: Ethical or Unacceptable?
More podcasts
Latest from Henry
With the Chevron Doctrine Overturned, the New ‘Judicial Veto’ of Regulations Will be Detrimental to Science and Business
The Anniversary of FDA's Landmark Approval of Genetically Engineered Human Insulin: A Cautionary Tale
Russia's Propaganda War on the U.S. Damages America's Economy, National Security, and Public Health
The Media and I: WHO and Mpox
More articles
Latest from Josh
NSAIDs: Pick Your Poison
Washing Stuff with Vinegar and Baking Soda: Green, But Not Clean
Supreme Court THC Case Highlights Our Flawed Drug Laws
In the Mood for a Salmon Sperm Facial? And a Chemistry Lesson?
More articles
Latest from Chuck
What I'm Reading (Oct. 31)
Thumb on the Scale? The Hidden Influence in Gender-Affirming Care Guidelines
'When We Count, We Change What Counts'
From a Drop of Blood to a Genome: The Future of Newborn Screening
More articles